These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
104 related items for PubMed ID: 5587361
1. Xanthelasma palpebrarum: an analysis of 141 cases. Chhetri MK, Chowdhury ND, De B. J Assoc Physicians India; 1967 Sep; 15(9):405-12. PubMed ID: 5587361 [No Abstract] [Full Text] [Related]
4. Treatment of xanthelasma palpebrarum by 1064-nm Q-switched Nd:YAG laser: a study of 11 cases. Fusade T. Br J Dermatol; 2008 Jan; 158(1):84-7. PubMed ID: 17916214 [Abstract] [Full Text] [Related]
5. [Xanthelasma palpebrarum and dyslipoproteinaemia: two retrospective studies (author's transl)]. Rouffy J, Chanu B, Bakir R, Goy-Loeper J, Bouthillier D, Goussault Y, Dreux C. Ann Dermatol Venereol; 1982 Jan; 109(3):231-5. PubMed ID: 7114736 [Abstract] [Full Text] [Related]
7. Xanthelasma palpebrarum treatment with a 1,450-nm-diode laser. Park EJ, Youn SH, Cho EB, Lee GS, Hann SK, Kim KH, Kim KJ. Dermatol Surg; 2011 Jun; 37(6):791-6. PubMed ID: 21605240 [Abstract] [Full Text] [Related]
8. Xanthelasma palpebrarum and its relation to atherosclerotic risk factors and lipoprotein (a). Ozdöl S, Sahin S, Tokgözoğlu L. Int J Dermatol; 2008 Aug; 47(8):785-9. PubMed ID: 18717856 [Abstract] [Full Text] [Related]
14. Lipid anomalies in cases of xanthelasma. Kahán A, Kahán IL, Timár V. Am J Ophthalmol; 1967 Feb; 63(2):320-5. PubMed ID: 6018667 [No Abstract] [Full Text] [Related]
17. A scoring-based clinical grading model for xanthelasma palpebrarum: predicting treatment frequency and prognosis. Xu Q, Yao Z, Yu X, Ying J, Zhu J, Lu L, Hu Z, Jiang H, Wang H. Arch Dermatol Res; 2024 Sep 12; 316(8):614. PubMed ID: 39266881 [Abstract] [Full Text] [Related]